Trials / Completed
CompletedNCT04513847
PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis
PsoVac: A Psoriatic Patient-based Survey on the Understanding of the Use of Vaccines While on Biologics During the Covid-19 Pandemic
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 661 (actual)
- Sponsor
- Dermatrials Research · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To determine if there is a need for further education on vaccines with psoriasis patients who are on a biologic. In regards to the COVID-19, it is important that psoriasis patients - whether on a biologic or not - understand whether they can have certain vaccines. That will depend on the type of vaccine that becomes available.
Conditions
Timeline
- Start date
- 2020-08-13
- Primary completion
- 2020-09-13
- Completion
- 2020-10-06
- First posted
- 2020-08-14
- Last updated
- 2020-10-08
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04513847. Inclusion in this directory is not an endorsement.